Skip to content
TrialScanner

NCT02889861

IMCgp100-401 Rollover Study

Phase 2TerminatedIMCRLead

Registry record

Lead sponsor
Immunocore Ltd
Conditions
Malignant Melanoma
Primary completion
Apr 22, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02889861 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02889861: IMCgp100-401 Rollover Study | TrialScanner